BNP Paribas Financial Markets
PYXS icon

BNP Paribas Financial Markets’s Pyxis Oncology PYXS Stock Holding History

BNP Paribas Financial Markets’s Portfolio PYXS Stock Details PYXS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.42K Sell
1,654
-22,625
-93% -$34.1K ﹤0.01% 5396
2025
Q4 		$27.9K Buy
24,279
+22,562
+1,314% +$79.6K ﹤0.01% 4928
2025
Q3 		$3.81K Sell
1,717
-116
-6% -$167 ﹤0.01% 5120
2025
Q2 		$2.02K Sell
1,833
-1,834
-50% -$2.07K ﹤0.01% 5055
2025
Q1 		$3.59K Sell
3,667
-2,243
-38% -$2.99K ﹤0.01% 4908
2024
Q4 		$9.22K Buy
+5,910
New +$17K ﹤0.01% 4854

Other funds holding PYXS

P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
GGI
GordonMD Global Investments Beverely Hills, California $144M AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
HP
HealthInvest Partners Stockholm, Sweden $372M AUM 59.89% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BNP Paribas Financial Markets's PYXS Position: Q1 2026 in Review

BNP Paribas Financial Markets reduced its Pyxis Oncology (PYXS) stake by 93% in Q1 2026, selling an estimated $34.1K and leaving 1,654 shares worth $2.42K. The position accounts for ﹤0.01% of the portfolio, ranked #5396.

BNP Paribas Financial Markets first reported a position in PYXS in Q4 2024 and has held it in 6 quarters since. The position peaked at $27.9K in Q4 2025. 78 funds tracked by Wall St. Rank hold PYXS as of Q1 2026.

  • BNP Paribas Financial Markets held 1,654 shares of Pyxis Oncology worth $2.42K as of Q1 2026.
  • BNP Paribas Financial Markets sold 22,625 Pyxis Oncology shares in Q1 2026, an estimated $34.1K.
  • Pyxis Oncology made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q1 2026, its #5396 holding.
  • BNP Paribas Financial Markets first reported a position in Pyxis Oncology in Q4 2024 and has held it in 6 quarters since.
  • BNP Paribas Financial Markets's Pyxis Oncology position peaked at $27.9K in Q4 2025.
  • 78 funds tracked by Wall St. Rank held Pyxis Oncology as of Q1 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q1 2026, filed 12 May 2026.